965 related articles for article (PubMed ID: 26473734)
1. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
2. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
[TBL] [Abstract][Full Text] [Related]
3. Oral vaccination against plague using Yersinia pseudotuberculosis.
Demeure CE; Derbise A; Carniel E
Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine.
Derbise A; Guillas C; Gerke C; Carniel E; Pizarro-Cerdà J; Demeure CE
Vaccine; 2020 Feb; 38(8):1888-1892. PubMed ID: 31964555
[TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
[TBL] [Abstract][Full Text] [Related]
8. A Recombinant Attenuated
Singh AK; Curtiss R; Sun W
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.
Tiner BL; Sha J; Ponnusamy D; Baze WB; Fitts EC; Popov VL; van Lier CJ; Erova TE; Chopra AK
Clin Vaccine Immunol; 2015 Dec; 22(12):1255-68. PubMed ID: 26446423
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK
Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803
[TBL] [Abstract][Full Text] [Related]
11. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
Sun W; Sanapala S; Henderson JC; Sam S; Olinzock J; Trent MS; Curtiss R
Infect Immun; 2014 Oct; 82(10):4390-404. PubMed ID: 25114109
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.
Branger CG; Sun W; Torres-Escobar A; Perry R; Roland KL; Fetherston J; Curtiss R
Vaccine; 2010 Dec; 29(2):274-82. PubMed ID: 20979987
[TBL] [Abstract][Full Text] [Related]
13. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
[TBL] [Abstract][Full Text] [Related]
14. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK
Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642
[TBL] [Abstract][Full Text] [Related]
15. Identification of New Virulence Factors and Vaccine Candidates for
Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
[TBL] [Abstract][Full Text] [Related]
16. A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model.
Zhang X; Qi Z; Du Z; Bi Y; Zhang Q; Tan Y; Yang H; Xin Y; Yang R; Wang X
Vaccine; 2013 May; 31(22):2539-42. PubMed ID: 23588087
[TBL] [Abstract][Full Text] [Related]
17. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
Branger CG; Fetherston JD; Perry RD; Curtiss R
Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.
Sun W; Sanapala S; Rahav H; Curtiss R
Vaccine; 2015 Nov; 33(48):6727-35. PubMed ID: 26514425
[TBL] [Abstract][Full Text] [Related]
19. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
Anderson GW; Leary SE; Williamson ED; Titball RW; Welkos SL; Worsham PL; Friedlander AM
Infect Immun; 1996 Nov; 64(11):4580-5. PubMed ID: 8890210
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bubonic and pneumonic plague using plant-derived vaccines.
Alvarez ML; Cardineau GA
Biotechnol Adv; 2010; 28(1):184-96. PubMed ID: 19931370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
